C
세니젠
188260KOSDAQ그외 기타 제품 제조업41.5 / 100
Reference Date: 2026-04-13
Financial Score10.0 / 40
News Sentiment12.5 / 25
Momentum9.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk, PBR raises overvaluation concerns. Rose 8.1% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Senigen is a food safety specialist company established in 2005, leveraging advanced molecular diagnostic technologies like PCR and NGS to provide comprehensive food safety solutions. It has developed key products such as Genelix (high-sensitivity PCR) and GeNext (world's first NGS panel for foodborne pathogen detection), and is expanding into cosmetics and microbiome industries.
Number of Employees
72people
Average Salary
55.7M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 10.954.0Point
PBR
5.33Industry Average 1.270.0Point
4.2x industry avg (risky)
ROE
-108.63Industry Average -16.543.5Point
6.6x industry avg (excellent)
Debt Ratio
153.31Industry Average 11.460.0Point
13.4x industry avg (risky)
Trend 2023~20252.5 / 10 points
Revenue Growth Rate
0.0 / 3
Avg ▼12.0% (2-year basis)
Operating Profit Growth Rate
2.5 / 3
Avg ▲17.4% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -84.6% (declining, 2yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position3.0Point
52w lower range (25%)
Current 1,826Won52-week high 2,85052-week low 1,484
1-month return5.0Point
1m +8.11% (rising)
Volume trend1.0Point
Volume dry-up
Detailed Disclosure
6 totalPositive 0Neutral 6Negative 0
- Neutral주식등의대량보유상황보고서(약식)2026-04-10
- Neutral주식등의대량보유상황보고서(일반)2026-03-19
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-03-19
- Neutral단기차입금증가결정2026-03-19
- Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-17